Oncology Market by Areas, Cancer Type, Treatment, Technology, Drugs, Stage, End Users, Geography and Competitive Analysis

In Oncology Market report, a systematic investment analysis has been performed which forecasts impending opportunities for the market players. The statistical and numerical data that has been included in this market report is represented with the tables, graphs and charts which eases the understanding of facts and figures. A proficient data and excellent forecasting techniques used in this report are synonymous with accurateness and correctness. Oncology Market report is a painstaking analysis of existing scenario of the market which covers several market dynamics. The market study of this global Oncology Market business report takes into consideration market attractiveness analysis where each segment is benchmarked based on its market size, growth rate, and general attractiveness.

Oncology Market By Areas (Medical, Surgical, Radiation), Cancer Type (Haematology Cancer, Ovarian Cancer, Pancreatic Cancer, Lung Cancer, Bladder Cancer, Prostate Cancer, Breast Cancer, Kidney Cancer, Others), Treatment (Combination Therapy, Adjuvant Therapy, Supportive Therapy, Palliative Care, Others), Technology (Car-T Cell Therapy, CRISPR/CAS9, Others), Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi, Others), Stage (Stage I, Stage II, Stage III, Stage IV), End Users (Hospitals, Specialty Clinics, Oncology Centers, Surgical Centers, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Request For Free Sample Report: https://www.delvens.com/get-free-sample/oncology-market-trends-forecast-till-2028

Key players in global oncology market are Roche, BMS Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceuticals, Pfizer Inc., Eli Lilly, Merck & Co., Amgen, Abbvie, Allogene Therapeutics, Juno Therapeutics, Morphosys, Arcus Biosciences, Atreca, Autolus, Novocure among others

Recent Developments

The companies have come up with various promotional activities in from of launch, investment, acquisition and other, for instance:

Boston Scientific announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc. a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals
Medtronic Plc announced its U.S. launch of OptiSphere (TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular tumors
Hence, tremendous progress have been made over the last decade and yet a lot more to come in the recent years.

Global oncology market is anticipated to reach USD 175.4 billion by 2020 growing at a CAGR of 7.1% during the forecasting period, 2020-2028. Oncology is one of the branches of medicine which deals prevention, diagnosis, and treatment of cancer. It includes the medical, surgical and radiation oncology. Medical oncology is of various types like chemotherapy, targeted therapy and immunotherapy. Factors such as increasing demand for minimally invasive procedures and the increasing number of targeted population are some of the major drivers for the oncology market.

Global Oncology Market Key Findings:

Global oncology market is segmented into areas, cancer type, treatment, technology, drugs, stage, end-user and geography.

Areas segment is segmented into Medical, Surgical and Radiation. Medical segment is further segmented into chemotherapy, Targeted Therapy and Immunotherapy. Surgical segment is further segmented into Image-Guided Biopsy, Fine Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Excisional Biopsy, Shave Biopsy, Punch Biopsy, Endoscopic Biopsy, Laparoscopic Biopsy, Bone Marrow Aspiration and Biopsy, Liquid Biopsy.

Cancer Type segment is segmented into Haematology Cancer, Ovarian Cancer, Pancreatic Cancer, Lung Cancer, Bladder Cancer, Prostate Cancer, Breast Cancer, Kidney Cancer and Others

Treatment segment is segmented into Combination Therapy, Adjuvant Therapy, Supportive Therapy, Palliative Care and Others

Technology segment is segmented into Car-T Cell Therapy, CRISPR/CAS9 and Others

Drugs segment is segmented into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi and Others

Stage segment is segmented into Stage I, Stage II, Stage III and Stage IV

End Users segment is segmented into Hospitals, Specialty Clinics, Oncology Centers, Surgical Centers and Others.

Geographically, global oncology market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Regional Analysis

North America region is the largest contributor to the oncology market in the forecast period 2020-2028 and Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for oncology market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Make an Inquiry: https://www.delvens.com/Inquire-before-buying/oncology-market-trends-forecast-till-2028

Contact Us:

UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
SALES@DELVENS.COM
WEBSITE: https://delvens.com/

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

This release was published on openPR.